- FRI 06 NOV
-
16:02
Investing.com - UK
Form 144 VERTEX PHARMACEUTICALS INC / MA For: 6 November
15 items
-
15:52
Nasdaq - stocks
XLV, ISRG, DHR, VRTX: ETF Inflow Alert
-
11:00
[DATA]
GuruFocus
Sector Trends: Technology Leads, Energy Sold on Nov. 4
-
08:31
[COMMENT]
TradingView
NASDAQ: VRTX — Bullish Consolidation Floor Retests Dynamic EMA
- THU 05 NOV
-
17:00
[DATA]
GuruFocus
Vertex Pharmaceuticals (VRTX) -- Resilience Amid Market Headwinds | Oak Ridge Small-Cap Q3 2026
-
11:05
[DATA]
GuruFocus
Capital Group Global Growth (CGGO) Buys $51.3 Million More ICE on Nov. 3
- WED 04 NOV
-
11:02
[DATA]
GuruFocus
Vertex Pharmaceuticals Inc (VRTX) Q3 2026 Earnings Call Highlights: Revenue Up 12% as CF, ...
-
05:06
[DATA]
GuruFocus
VRTX SWOT Analysis: Vertex Pharmaceuticals Inc's Strong Financial Position Highlighted in 10-Q ...
- TUE 03 NOV CLOSE 530.76 -4.0% VOL 1.6×
- 21:04 [FILING] 10-Q sec.gov
-
18:37
[DATA]
GuruFocus
VRTX Maintained by JP Morgan -- Price Target Raised to $570
3 items · also GuruFocus
-
18:34
[DATA]
GuruFocus
VRTX Maintains Buy Rating -- Price Target Raised to $725
2 items
-
18:31
[DATA]
GuruFocus
VRTX Maintained by Morgan Stanley -- Price Target Lowered to $660
3 items
-
18:30
[DATA]
GuruFocus
VRTX Maintains Rating by Scotiabank -- Price Target Raised to $660
-
16:33
[DATA]
GuruFocus
VRTX Maintained by TD Cowen -- Price Target Raised to $575
-
16:00
[DATA]
GuruFocus
VRTX Maintained by Wells Fargo -- Price Target Raised to $650
3 items · also GuruFocus
-
15:44
[DATA]
GuruFocus
VRTX Maintained by RBC Capital -- Price Target Raised to $600
-
12:31
[DATA]
GuruFocus
VRTX Maintained by Cantor Fitzgerald -- Price Target Raised to $619
4 items
-
11:30
[DATA]
GuruFocus
Company Guidance Roundup: Palantir, Upwork on Nov. 2
-
11:30
[DATA]
GuruFocus
Vertex Pharmaceuticals Raises Fiscal 2026 Revenue Guidance on Nov. 2
2 items
-
06:55
[DATA]
GuruFocus
Vertex Pharmaceuticals Reports Q3 2026 Revenue Growth, Ticker VRTX
4 items · also GuruFocus
- MON 02 NOV CLOSE 553.15 -1.0% VOL 2.3×
-
23:56
[DATA]
GuruFocus
Vertex Pharmaceuticals (VRTX) Revises 2026 Revenue Forecast Slightly Below Expectations
- 21:05 [FILING] 8-K (Item 2.02,9.01) sec.gov
- SUN 01 NOV
-
22:55
[DATA]
GuruFocus
Vertex Pharmaceuticals (VRTX) Set to Report Q3 Earnings on November 2
- FRI 30 OCT CLOSE 558.88 +3.5% VOL 2.3×
- THU 29 OCT CLOSE 540.00 +1.9% VOL 1.2×
- WED 28 OCT CLOSE 529.69 +1.7% VOL 1.0×
- TUE 27 OCT CLOSE 521.03 +0.7% VOL 0.8×
- MON 26 OCT CLOSE 517.49 -1.2% VOL 1.0×
- FRI 23 OCT CLOSE 523.93 -2.1% VOL 0.7×
- THU 22 OCT CLOSE 535.17 +2.0% VOL 1.4×
- 21:06 [FILING] 3 — FORM 3 sec.gov
- WED 21 OCT CLOSE 524.52 +1.9% VOL 1.2×
- TUE 20 OCT CLOSE 514.65 +2.5% VOL 1.0×
- 21:09 [FILING] 8-K (Item 5.02) sec.gov
- MON 19 OCT CLOSE 501.95 +0.4% VOL 1.1×
- FRI 16 OCT CLOSE 499.74 -1.8% VOL 1.2×
- THU 15 OCT CLOSE 508.75 +2.1% VOL 2.0×
- WED 14 OCT CLOSE 498.50 +2.7% VOL 1.9×
- TUE 13 OCT CLOSE 485.22 -4.3% VOL 1.1×
- MON 12 OCT CLOSE 507.00 -0.6% VOL 0.9×
- FRI 09 OCT CLOSE 510.08 +1.4% VOL 1.4×
- THU 08 OCT CLOSE 503.25 -0.5% VOL 1.5×
- WED 07 OCT CLOSE 505.64 +0.7% VOL 0.8×
- TUE 06 OCT CLOSE 502.31 -0.2% VOL 0.8×
- MON 05 OCT CLOSE 503.50 -0.2% VOL 0.9×
- FRI 02 OCT CLOSE 504.73 -0.4% VOL 0.9×
- THU 01 OCT CLOSE 506.74 -3.1% VOL 1.2×
- WED 30 SEPT CLOSE 522.81 -0.7% VOL 1.1×
- TUE 29 SEPT CLOSE 526.73 -0.2% VOL 0.7×